Microvast . Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Microvast . Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||
net profit/ | 61,790,000 | ||||||||||||
adjustments to reconcile net profit/(loss) to net cash from operating activities: | |||||||||||||
loss/(gain) on disposal of property, plant and equipment | 95,000 | ||||||||||||
gain on debt restructuring | -389,000 | ||||||||||||
depreciation of property, plant and equipment | 7,985,000 | 7,615,000 | 7,530,000 | 7,442,000 | 7,470,000 | 7,498,000 | 4,846,000 | 4,905,000 | 4,892,000 | 4,650,000 | 4,784,000 | 5,067,000 | 5,310,000 |
amortization of land use right and intangible assets | 192,000 | 194,000 | 193,000 | 194,000 | 194,000 | 194,000 | 205,000 | 137,000 | 140,000 | 143,000 | |||
noncash lease expenses | 666,000 | 682,000 | 677,000 | 663,000 | 664,000 | 656,000 | 643,000 | 807,000 | 658,000 | 552,000 | 550,000 | 555,000 | 557,000 |
share-based compensation | 703,000 | 551,000 | 6,301,000 | 12,123,000 | 11,865,000 | 13,330,000 | 15,862,000 | 17,850,000 | 17,929,000 | 17,883,000 | 19,275,000 | 25,520,000 | 28,130,000 |
changes in fair value of warrant and convertible loan | -43,160,000 | -2,766,000 | |||||||||||
allowance of credit losses | 1,358,000 | ||||||||||||
product warranty | 4,825,000 | 2,473,000 | 4,024,000 | 3,060,000 | 3,269,000 | 3,671,000 | 3,567,000 | 2,920,000 | 2,530,000 | 5,834,000 | 2,028,000 | 3,550,000 | 2,685,000 |
changes in operating assets and liabilities: | |||||||||||||
notes receivable | -5,263,000 | -2,674,000 | -1,116,000 | -299,000 | 10,577,000 | -2,966,000 | -2,564,000 | 1,532,000 | -21,340,000 | 1,801,000 | 22,033,000 | -7,179,000 | -13,468,000 |
accounts receivable | -14,108,000 | -9,366,000 | -11,465,000 | 17,611,000 | 12,011,000 | -20,848,000 | -11,162,000 | -22,042,000 | 32,293,000 | -33,900,000 | 16,832,000 | -30,602,000 | 8,746,000 |
inventories | 15,783,000 | 3,598,000 | -2,690,000 | -17,795,000 | 16,341,000 | -19,933,000 | -37,863,000 | -9,571,000 | -7,039,000 | -4,177,000 | -23,611,000 | -11,028,000 | -4,878,000 |
prepaid expenses and other current assets | -2,402,000 | 949,000 | -6,122,000 | 4,157,000 | 4,305,000 | -1,625,000 | -5,824,000 | -5,985,000 | -857,000 | 7,392,000 | -5,453,000 | 4,275,000 | -2,586,000 |
amounts due to related parties | -5,000 | ||||||||||||
operating lease right-of-use assets | -654,000 | 41,000 | 107,000 | -1,605,000 | -323,000 | 142,000 | 262,000 | -3,357,000 | -2,493,000 | -91,000 | -24,000 | -315,000 | -18,945,000 |
other non-current assets | -1,388,000 | -10,010,000 | 9,081,000 | 231,000 | -275,000 | 106,000 | -852,000 | -89,000 | 288,000 | -498,000 | 105,000 | 162,000 | -51,000 |
notes payable | -4,150,000 | -2,421,000 | 6,078,000 | -14,610,000 | 1,042,000 | 22,563,000 | -10,553,000 | -14,581,000 | -936,000 | -6,452,000 | 705,000 | 9,846,000 | 9,391,000 |
accounts payable | -8,547,000 | 2,711,000 | -16,718,000 | -2,673,000 | -27,843,000 | 15,176,000 | 41,629,000 | 15,727,000 | -3,956,000 | 7,675,000 | -1,337,000 | 9,413,000 | -8,605,000 |
advance from customers | 462,000 | 1,033,000 | 1,928,000 | -431,000 | -1,694,000 | -11,464,000 | 1,483,000 | 211,000 | -1,179,000 | 47,414,000 | 2,378,000 | 1,167,000 | 2,063,000 |
accrued expenses and other liabilities | -6,812,000 | 16,608,000 | -20,720,000 | -1,751,000 | -10,623,000 | 7,976,000 | -2,394,000 | 4,454,000 | -3,434,000 | -12,471,000 | 1,501,000 | -7,539,000 | -6,165,000 |
operating lease liabilities | -340,000 | -738,000 | -602,000 | 233,000 | -500,000 | -494,000 | -604,000 | 2,125,000 | 1,239,000 | -390,000 | -449,000 | -308,000 | 16,146,000 |
other non-current liabilities | 528,000 | -4,023,000 | 4,868,000 | 2,937,000 | -126,000 | 635,000 | -104,000 | -107,000 | -108,000 | -104,000 | -106,000 | 1,231,000 | -75,000 |
net cash generated from operating activities | 7,169,000 | ||||||||||||
cash flows from investing activities | |||||||||||||
purchases of property, plant and equipment | -2,346,000 | -355,000 | -14,180,000 | -2,945,000 | -10,241,000 | -33,214,000 | -59,944,000 | -57,708,000 | -35,922,000 | -66,158,000 | -16,807,000 | -26,854,000 | -41,061,000 |
proceeds on disposal of property, plant and equipment | 14,000 | 175,000 | 9,650,000 | 28,000 | 152,000 | 770,000 | 231,000 | 308,000 | 340,000 | 2,000 | 1,000 | 1,000 | 1,000 |
proceeds from maturity of short-term investments | 0 | 0 | 0 | 5,564,000 | |||||||||
net cash from investing activities | -2,332,000 | -180,000 | -4,530,000 | -2,917,000 | -4,525,000 | -12,485,000 | -59,719,000 | -57,576,000 | -35,825,000 | -91,226,000 | -16,806,000 | -26,853,000 | -41,060,000 |
cash flows from financing activities | |||||||||||||
proceeds from borrowings | 28,187,000 | 29,911,000 | 21,682,000 | 18,780,000 | 9,207,000 | 4,848,000 | 4,384,000 | 45,242,000 | |||||
repayment of bank borrowings | -13,062,000 | -34,424,000 | -8,375,000 | -10,929,000 | -12,520,000 | -7,833,000 | -2,347,000 | 0 | -7,150,000 | ||||
repayment of bonds payable | -1,375,000 | ||||||||||||
deferred payment related to purchases of property, plant and equipment | -4,287,000 | -5,766,000 | |||||||||||
net cash generated from financing activities | 9,463,000 | -9,046,000 | 18,147,000 | 22,228,000 | 6,260,000 | 20,888,000 | 6,860,000 | 909,000 | 4,384,000 | ||||
effect of exchange rate changes | -907,000 | -2,241,000 | 2,295,000 | -1,642,000 | -5,251,000 | -4,473,000 | 1,094,000 | -3,652,000 | 470,000 | 2,736,000 | -7,459,000 | -4,461,000 | 598,000 |
increase/ (decrease) in cash, cash equivalents and restricted cash | 13,393,000 | ||||||||||||
net income | -105,438,000 | 13,247,000 | -78,441,000 | -24,825,000 | -24,591,000 | -26,172,000 | -26,078,000 | -29,571,000 | -33,698,000 | -36,544,000 | -44,182,000 | -43,776,000 | |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||
loss /(gain) on disposal of property, plant and equipment | |||||||||||||
interest expense | 0 | 1,626,000 | |||||||||||
amortization of land use rights and intangible assets | |||||||||||||
changes in fair value of warrant liability and convertible loan | |||||||||||||
write-down for obsolete inventories | 254,000 | 1,295,000 | |||||||||||
impairment income from long-lived assets | |||||||||||||
amounts due from/to related parties | |||||||||||||
net cash generated from (used in) operating activities | |||||||||||||
purchase of short-term investments | -5,541,000 | -6,000 | -176,000 | -243,000 | |||||||||
proceeds from bank borrowings | |||||||||||||
convertible loan borrowed from a shareholder | |||||||||||||
payment for debt issue costs | 0 | 0 | |||||||||||
cash, cash equivalents and restricted cash at beginning of the year | |||||||||||||
cash, cash equivalents and restricted cash at end of the year | |||||||||||||
reconciliation to amounts on consolidated balance sheets | |||||||||||||
cash and cash equivalents | |||||||||||||
restricted cash | |||||||||||||
total cash, cash equivalents and restricted cash | |||||||||||||
supplemental disclosure of cash flow information | |||||||||||||
interest paid | |||||||||||||
income tax paid | |||||||||||||
non-cash investing and financing activities | |||||||||||||
payable for purchase of property, plant and equipment | |||||||||||||
loss on disposal of property, plant and equipment | 6,000 | 2,000 | 824,000 | -2,000 | 1,000 | 12,000 | |||||||
(reversal)/ allowance of credit losses | -992,000 | 177,000 | 578,000 | ||||||||||
impairment income from long-lived asset | 12,000 | ||||||||||||
net cash from operating activities | -4,953,000 | -29,342,000 | -29,842,000 | -11,166,000 | 4,940,000 | -38,621,000 | -24,914,000 | ||||||
capex | -33,214,000 | -59,944,000 | -57,708,000 | -35,922,000 | -16,807,000 | -26,854,000 | -41,061,000 | ||||||
free cash flows | -38,167,000 | -89,286,000 | -87,550,000 | -47,088,000 | -11,867,000 | -65,475,000 | -65,975,000 | ||||||
convertible loan borrowing from a shareholder | 13,000,000 | ||||||||||||
increase in cash, cash equivalents and restricted cash | 10,483,000 | ||||||||||||
cash, cash equivalents and restricted cash at beginning of the period | 0 | 0 | 88,189,000 | 0 | 0 | 302,617,000 | 0 | 0 | 536,109,000 | ||||
cash, cash equivalents and restricted cash at end of the period | 10,483,000 | 17,780,000 | 86,704,000 | -81,107,000 | -90,161,000 | 260,480,000 | 18,767,000 | -73,801,000 | 470,733,000 | ||||
loss/ (gain) on disposal of property, plant and equipment | 50,000 | -34,000 | |||||||||||
net cash (used in) generated from operating activities | 111,000 | 2,031,000 | |||||||||||
changes in fair value of warrant liability | -42,000 | -84,000 | 42,000 | 0 | -17,000 | -58,000 | -101,000 | -1,255,000 | 435,000 | ||||
decrease in cash, cash equivalents and restricted cash | -1,485,000 | -81,107,000 | -90,161,000 | -42,137,000 | 18,767,000 | -73,801,000 | -65,376,000 | ||||||
changes in fair value of bridge notes | |||||||||||||
benefit from obsolete inventories | 2,685,000 | 0 | 1,641,000 | 1,229,000 | 1,448,000 | 471,000 | |||||||
impairment income from property, plant and equipment | 31,000 | 422,000 | 252,000 | 1,053,000 | 487,000 | 6,000 | |||||||
loans borrowing from related parties | |||||||||||||
repayment of related party loans | |||||||||||||
cash received from the trust account upon merger, net of transaction costs | |||||||||||||
cash received from private investment in public equity | |||||||||||||
payment to exited noncontrolling interests | |||||||||||||
issuance of bridge notes | |||||||||||||
allowance/(reversal) of credit losses | |||||||||||||
reversal of credit losses | 262,000 | -1,094,000 | -545,000 | ||||||||||
adjustments to reconcile net income to net cash generated from/(used in) operating activities: | |||||||||||||
(reversal)/allowance of doubtful accounts | |||||||||||||
income tax payables | |||||||||||||
net cash generated from/(used in) operating activities | |||||||||||||
net cash (used in)/generated from financing activities | |||||||||||||
payable for redemption of noncontrolling interest | |||||||||||||
changes in fair value of convertible notes | |||||||||||||
amount due from/to related parties | 0 | 0 | 85,000 | ||||||||||
merger and private investment in public equity (“pipe”) financing | |||||||||||||
payment for transaction fee in connection with the merger | |||||||||||||
issuance of convertible notes | |||||||||||||
(reversal) allowance of credit losses | |||||||||||||
net cash generated from (used in) financing activities | |||||||||||||
loans to related party |
We provide you with 20 years of cash flow statements for Microvast . stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Microvast . stock. Explore the full financial landscape of Microvast . stock with our expertly curated income statements.
The information provided in this report about Microvast . stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.